Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367365 · ClinicalTrials.gov registry record
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 75
- Enrollment target
NCT02367365: Completed study, sponsored by Duke University.
NCT02367365 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02367365 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Neovascular Age-Related Macular Degeneration (NV AMD) remains the leading cause of vision loss among people over 65. Intravitreal injections with drugs that block VEGF have revolutionized treatment of NV AMD. However, less than 40% of treated patients have clinically significant imporovement in vision. In this study, we will determine the relative frequency of neovascular subtypes in two groups: 1) a representative, treatment-naive NV AMD patient population, and 2) a population of patients who develop recurrent NV AMD activity while off treatment and assess the frequency of persistent disease activity (PDA) according to specific neovascular morphologic subtypes. This information will clarify the scope of the PDA problem and will identify patients with PDA who may benefit from additional therpeutic strategies.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-12 |
What the finished NCT02367365 record still lists
NCT02367365 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT02367365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02367365 about?
NCT02367365 is a clinical study titled "Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD". Neovascular Age-Related Macular Degeneration (NV AMD) remains the leading cause of vision loss among people over 65. Intravitreal injections with drugs that block VEGF have revolutionized treatment of NV AMD. However, less than 40% of treated patients have clinically significant imporovement in visi...
What is the current status of trial NCT02367365?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2014-12. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02367365?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02367365?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia